OHI climbs 6.08% from 43.47 support, eyes 46.36 high
$Omega Healthcare Investors(OHI)$ Omega Healthcare Investors(OHI) Jumps +6.08%: REIT Defies Skeptics, Nears 52-Week High Latest Close Data Closed at $45.57 (ET 2026-02-05), up +6.08% with daily high at $46.17, just $0.19 shy of its 52-week high ($46.36). Core Market Drivers The surge comes amid renewed investor focus on high-yield income plays. The stock's attractive ~5.88% dividend yield likely drew capital as broader market volatility increased. Recent 5-day capital flow data was mixed but culminated in strong single-day net inflows. Technical Analysis Volume was robust at 3.79M shares (VR=1.50), confirming the breakout. The RSI(6) spiked to 73.9, indicating strong short-term momentum but nearing overbought territory. Crucially, the MACD histogra
Will NHC extend its 5.58% gain above 159.90 toward 161.80?
$National Healthcare(NHC)$ National Healthcare Corp(NHC) Jumps +5.58%: Reaching 52-Week High, Momentum Intact Latest Close Data On 2026-02-05 (ET), NHC closed at $159.90, up +5.58% (+$8.45). The stock hit its 52-week high of $161.80 during the session, closing just $1.90 below that peak. Core Market Drivers The rally appears to be driven by strong underlying financial performance, with a trailing EPS of $6.48 and solid ROE of 10.12%. The stock also offers a dividend yield of 1.56%, attracting income-focused investors in the stable healthcare sector. Technical Analysis Volume was 77.5K shares with a Volume Ratio of 1.10, indicating slightly above-average participation. The 6-day RSI is at a high 85.88, signaling overbought conditions and potential f
Gilead up 2.15% at 149 is a near-term pullback likely
$Gilead Sciences(GILD)$ Gilead Sciences, Inc. (GILD) Tests 52-Week High, Up +2.15%: Biotech Giant Hits $150.50, Awaits Breakout Latest Close Data Closed at $149.37 on 2026-02-05, up +2.15% (+$3.14). The stock is currently trading at its 52-week high of $150.50. Core Market Drivers The surge is supported by sustained strong capital inflows over the past five trading days, indicating institutional accumulation. A solid 2.10% dividend yield adds defensive appeal amid broader market volatility. Recent executive stability and consistent institutional holding (e.g., Vanguard, BlackRock) underpin long-term confidence. Technical Analysis Volume was strong at 9.14M shares (Volume Ratio: 1.21), confirming the upward move. The MACD shows a bullish trend with
SE up 2.2% trading 45% below 52 week high is 108 the bottom
$Sea Ltd(SE)$ Sea Ltd (SE) Rebounds +2.17%: Deep Value Play Emerges at $108, RSI Shows Oversold Bounce Latest Close Data: Closed at $108.57 on Feb 5, 2026, up +2.17%. Currently trading ~45% below its 52-week high of $199.30. Core Market Drivers: The stock is stabilizing after a significant decline from recent highs. Key institutional shareholders like Baillie Gifford have been reducing their stakes, contributing to selling pressure. The current price action suggests a potential bottoming process as the valuation becomes more attractive. Technical Analysis: Volume was steady at 7.9M shares (VR 1.01). The RSI(6) at 23.3 has bounced from deeply oversold levels (<12), indicating a short-term relief rally. However, the MACD remains bearish with a nega
ETSY Rebounds From Oversold Levels, Tests Key $55 Resistance
$Etsy(ETSY)$ Etsy, Inc. (ETSY) Rallies +2.58%: Oversold Rebound Attempts to Clear $55 Barrier Latest Close Data ETSY closed at $54.46 on Feb 5, up +2.58% (+$1.37). It remains ~28.8% below its 52-week high of $76.52. Core Market Drivers The stock is rebounding from deeply oversold levels. Recent positive 5-day capital flow data (highlighting significant inflows on Feb-02 and Feb-04) suggests potential accumulation near the $53 support zone. The broader e-commerce sector sentiment is stabilizing. Technical Analysis Volume was elevated at 6M shares (Volume Ratio 1.55), confirming the bullish move. The RSI(6) jumped to 38.78, moving out of the oversold territory (<30). MACD remains negative at -1.75, with DIF (-1.20) below DEA (-0.33), indicating t
💰From Trading Alone to Million-Dollar Profits: Inside the Minds of Trade to Win Champion
At the Tiger Brokers “Trade to Win” Season 4 meetup held in Singapore in March 2025, three top-ranked contestants — @Sean , @EliteEquity, and @Caldron — were joined by special guest Bradley, who has achieved financial independence through trading. Together, they shared their personal journeys, core strategies, and market outlooks.Read more>>🎉Tiger Brokers Celebrates "Trade to Win Season 4" Winners and Announces 2026 SeasonTrade to win winners events - on-site photosTrade to win winners events - on-site photosTrade to win winners events - on-site photosSpecial notes: The below is a highligh of the Trade to Wi
💰💰Congrats to the Impressive Earnings & Success Stories by Cash Boost Account!
Hello, Tigers!🐯 How's your trade going this week? We started rewarding the sharing of winning trades in the Telegram CashBoost group every week. In this activity, you can earn tiger coins and receive tiger-themed peripheral souvenirs. Welcome to join the Telegram group! 💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉 Follow @Tiger_Contra to see more Dividend Picks & High Alpha Stocks analysis. We have been excited to see many Tigers in the community who have opened a Cash Boost account and are sharing their profitable trades. This week, 5 users have already profited a lot through Contra🎉🎉 On Feb 5th, we're excited to see
SWKS Up 3.25%: Breakout Ahead or Just a Defensive Pause?
$Skyworks Solutions(SWKS)$ Skyworks Solutions, Inc.(SWKS) Up +3.25%: Defensive Rebound to $61, Consolidation Phase in Play Latest Close Data Closed at $60.92 on 2026-02-05, up +3.25% from the previous close. The stock remains ~33% below its 52-week high of $90.90. Core Market Drivers The rebound appears to be a defensive rotation into high-dividend tech. The stock's attractive ~4.66% yield and relatively stable RF semiconductor demand in auto/industrial segments are providing support amidst broader market volatility. Technical Analysis Volume of 6.93M shares (VR=1.21) confirms the up move. MACD (DIF: -1.42, DEA: -1.86, MACD: +0.86) has formed a bullish crossover above the signal line. RSI(6) at 67.83 is approaching overbought territory, suggesting
$AxoGen(AXGN)$ AXGN: take profit of close to 100%. Continue to consolidate positions and preserving cash to prepare to take up assignments on some of the short puts that will likely ended up in the money by Friday 6th Feb. Happy to be collecting on this trade.
The market has reached a clear pricing consensus on $NVIDIA(NVDA)$ . The upward revisions to hyperscaler AI capex for 2026, as well as the successful ramp of the Blackwell platform, are now fully reflected in the stock. As a result, NVDA’s valuation framework has shifted away from being a pure “AI beta” trade toward a more structural question: Can the winner of the AI infrastructure buildout sustain its advantage into 2027 and beyond? At this stage, marginal buyers are increasingly focused on long-term visibility rather than near-term upside surprises. NVDA has effectively entered a valuation regime where narrative matters more than near-term financials. Core Investment Thesis 2027 Revenue Visibility Is the New Valuation Anchor Upside to NVDA’s 20
SG Space Ambitions vs. Valuation: Can a $32.6B Order Book Justify the 11x P/B? |🦖EP1410
🟩 Singapore is officially launching its National Space Agency in April 2026, and the hype surrounding ST Engineering (S63) has reached stratospheric levels. With a massive $32.6 billion order book and headlines promising a new era of satellite constellations, the narrative is intoxicating. However, with the stock trading near $9.95 and P/E ratios hitting 40x, smart investors are asking the ten-dollar question: Are we buying into the final frontier, or just chasing a financial mirage?In this deep dive from the Pit, we strip away the sci-fi headlines to examine the hard numbers behind the "National Champion." We analyze the new Incremental Dividend Payout Model to see if the future yield can actually justify the current premium. We also put S63 through a rigorous Health Check, comparing its
🌟🌟🌟Being a dividend focused investor, I like $Valero(VLO)$ . Valero isn't a glamorous tech stock . It doesn't promise moonshots or hype. What it offers is something far rarer in a chaotic world: cash flow discipline , operational excellence & leverage to geopolitical shocks. With tensions rising in Iran, Valero sits in a uniquely advantaged position. Valero has been one of the strongest performing refiners over the past few years. Refiners tend to outperform when oil prices rise due to geopolitical risk, supply disruptions and global fuel demand stays firm. Valero has benefited from all these factors. Valero is one of the lowest cost refiners in the US. It exports heavily to regions affected by supply tightness.&
Arm Earnings: The High Cost of Innovation and the Wait for an AI Takeover Global semiconductor IP leader $Arm Holdings(ARM)$ released its FY26 Q3 earnings after hours, but the stock tumbled more than 7% in the aftermath, dragged down by weak guidance from mobile chip giant $Qualcomm(QCOM)$ , which reported earnings simultaneously. Let's peel back the layers of this report to see the true quality of the results and identify exactly what has the market worried. Three Things to Watch Data Center Royalties Continue to Double, but Mobile Growth Faces Pressure $Arm Holdings (ARM.US)$ reported Royalty revenue of $737 million for
If I could only go all-in on one, my pick would be OpenAI. Generative AI is rapidly becoming the core layer of the digital economy & OpenAI has unmatched scale, distribution & monetization momentum. An IPO wouldn’t just be a listing — it could reshape major index weightings, similar to what Microsoft once did. SpaceX remains the most visionary long-term bet. Its launch dominance and Starlink’s recurring cash flows make the trillion-dollar valuation plausible, but it’s a capital-intensive, regulation-sensitive play that requires patience and near-flawless execution. The upside is enormous, but so is the complexity. Anthropic is the strategic dark horse. Backed by Google and Amazon, it offers institutions a credible alternative to OpenAI with potentially better valuation discipline.